Product
23 Valent Pneumococcal Polysaccharide Vaccine
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Single Center, Randomized, Double-blind, and Intergroup Control Clinical Study to Evaluation on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of 23 Valent Pneumococcal Polysaccharide VaccineStatus: Active (not recruiting), Estimated PCD: 2024-12-30